Editorial Comment on "Peritumoral Infiltration of Regulatory T Cells Reduces the Therapeutic Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Carcinoma In Situ".
作者信息
Takamatsu Kimiharu
机构信息
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Department of Urology, Keio University School of Medicine, Tokyo, Japan.
出版信息
Int J Urol. 2025 Jun;32(6):747-748. doi: 10.1111/iju.70089. Epub 2025 May 2.
Abstract
摘要
相似文献
1
Editorial Comment on "Peritumoral Infiltration of Regulatory T Cells Reduces the Therapeutic Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Carcinoma In Situ".关于“调节性T细胞的瘤周浸润降低卡介苗治疗原位膀胱癌的疗效”的社论评论
Int J Urol. 2025 Jun;32(6):747-748. doi: 10.1111/iju.70089. Epub 2025 May 2.
2
Peritumoral Infiltration of Regulatory T Cells Reduces the Therapeutic Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Carcinoma In Situ.调节性T细胞的瘤周浸润降低了卡介苗治疗原位膀胱癌的疗效。
Int J Urol. 2025 Jun;32(6):737-746. doi: 10.1111/iju.70044. Epub 2025 Mar 14.
3
Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: effect of bacillus Calmette-Guerin viability on treatment results.卡介苗膀胱内灌注治疗浅表性膀胱癌：卡介苗活性对治疗结果的影响
J Urol. 1985 Jul;134(1):48-53. doi: 10.1016/s0022-5347(17)46976-x.
4
Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.肿瘤相关巨噬细胞浸润增加与膀胱原位癌经膀胱内卡介苗灌注后的预后不良相关。
J Urol. 2009 Apr;181(4):1894-900. doi: 10.1016/j.juro.2008.11.090. Epub 2009 Feb 23.
5
Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder.预测膀胱原位癌患者对卡介苗（BCG）的反应。
Urol Oncol. 2014 Jan;32(1):45.e23-30. doi: 10.1016/j.urolonc.2013.06.008. Epub 2013 Sep 18.
6
An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.他汀类药物使用对卡介苗治疗膀胱移行细胞癌疗效的影响分析。
J Urol. 2008 Oct;180(4):1297-300; discussion 1300. doi: 10.1016/j.juro.2008.06.034. Epub 2008 Aug 15.
7
Insignificant role of bacillus Calmette-Guérin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial.卡介苗维持治疗在中高危非肌层浸润性膀胱癌经尿道膀胱肿瘤完全切除术后的作用不显著：一项随机试验的结果
Int J Urol. 2016 Oct;23(10):854-860. doi: 10.1111/iju.13167. Epub 2016 Jul 15.
8
Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma.卡介苗用于浅表性膀胱癌患者的经验。
J Urol. 1982 Jul;128(1):27-30. doi: 10.1016/s0022-5347(17)52736-6.
9
Intravesical bacillus Calmette-Guérin efficiently reduces p70S6K1 but not 4E-BP1 phosphorylation in nonmuscle invasive bladder cancer.膀胱内卡介苗能有效降低非肌肉浸润性膀胱癌中 p70S6K1 的磷酸化，但不能降低 4E-BP1 的磷酸化。
J Urol. 2015 Feb;193(2):682-9. doi: 10.1016/j.juro.2014.08.106. Epub 2014 Sep 6.
10
The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guérin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial.经膀胱内吉西他滨联合 1/3 剂量卡介苗灌注治疗对非肌层浸润性膀胱癌患者生活质量的影响：一项前瞻性、随机、Ⅱ期临床试验的结果。
J Urol. 2013 Sep;190(3):857-62. doi: 10.1016/j.juro.2013.03.097. Epub 2013 Mar 29.
本文引用的文献
1
Peritumoral Infiltration of Regulatory T Cells Reduces the Therapeutic Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Carcinoma In Situ.调节性T细胞的瘤周浸润降低了卡介苗治疗原位膀胱癌的疗效。
Int J Urol. 2025 Jun;32(6):737-746. doi: 10.1111/iju.70044. Epub 2025 Mar 14.
2
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.卡介苗无反应性非肌层浸润性膀胱癌的保膀胱治疗：国际膀胱癌小组关于最佳治疗顺序和患者选择的建议
Eur Urol. 2024 Dec;86(6):516-527. doi: 10.1016/j.eururo.2024.08.001. Epub 2024 Aug 24.
3
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.BCG 疗法下调恶性细胞上的 HLA-I 以颠覆膀胱癌中的抗肿瘤免疫反应。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI145666.
4
Value of tumour-infiltrating immune cells in predicting response to intravesical BCG in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis.肿瘤浸润免疫细胞在预测非肌层浸润性膀胱癌患者膀胱内卡介苗治疗反应中的价值：系统评价和荟萃分析。
BJU Int. 2021 Jun;127(6):617-625. doi: 10.1111/bju.15276. Epub 2020 Nov 9.
5
Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort.膀胱内卡介苗治疗非肌肉浸润性膀胱癌的肿瘤微环境中的调节性 T 细胞和肿瘤相关巨噬细胞：一项日本队列的长期随访研究。
Int J Mol Sci. 2017 Oct 19;18(10):2186. doi: 10.3390/ijms18102186.
Zotero 插件